EpiScalp is a new tool designed to improve the accuracy of EEG recordings and reduce epilepsy misdiagnoses by as much as 70%, ...
In the United States, nearly three million adults 18 years and older reported having active epilepsy during 2021 and 2022.
"Ceribell significantly improves our confidence in clinical decisions and guides our treatments more effectively," said Sarah ...
A team of scientists from the Center for Neuroscience Imaging Research (CNIR) at the Institute for Basic Science (IBS) has ...
Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and ...